Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Azafaros Appoints Chief Operating Officer and Head of Finance
Azafaros today announced two appointments to their executive management team with Silvia Ragno, PhD, joining […]
Lena Wagner & Simone Marquardt, Raumedic, on Components for the Pharmaceutical and MedTech Industries
In this video, Lena Wagner and Simone Marquardt from Raumedic discuss the components that the […]
Catherine Bianchi, Saint-Gobain, on Pharmaceutical Products
In the video, Catherine Bianchi, Marketing Group Leader of Bioprocess Solutions at Saint-Gobain, introduces the […]
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a […]
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
Oricell Therapeutics, a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, […]
Dawn Health partners with leading Pharmaceutical Company, Novartis, to Transform Chronic Care
Dawn Health, a global leader in digital health, has announced a strategic partnership with Novartis, […]
Univar Solutions Expands Pharmaceutical Ingredients Portfolio Through New Distribution Agreement with SI Group
Univar Solutions Brasil, a subsidiary of Univar Solutions, a leading global solutions provider to users […]
Chong Kun Dang Pharm and Synaffix Enter a Licensing Agreement
Chong Kun Dang Pharm (CKD), a global pharmaceutical company based in South Korea, and Synaffix […]
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology
Oricell Therapeutics, an innovative pharmaceutical company committed to the development of clinical-stage oncology cell therapies, […]
Moleculin Receives Approval in Italy to Conduct Trial for the Treatment of Acute Myeloid Leukemia
Moleculin Biotech, a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more